MET - MetLife, Inc.
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced he
Axxcess Wealth Management LLC cut its holdings in shares of MetLife, Inc. (NYSE: MET) by 46.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,011 shares of the financial services provider's stock after selling 13,162 shares during the
MetLife trades with a single-digit P/E multiple and about 10% earnings growth. With strength across segments and costs in control, the company continues to reward shareholders. The chart suggests significant upside leading into and through the Q3 earnings report due out next month.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
MET expands its pet insurance reach through ChatGPT, simplifying coverage exploration and quotes while targeting growing demand for affordable pet care.
Volatility is back as inflation, geopolitical tensions and AI spending concerns mount. SLF, KO, MO, KDP and MET are five low-beta, high-yield stocks to consider for the rest of 2026.
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market closes. The earnings news release, financial supplement and related materials will be posted on MetLife's Investor Relations webpage at investor.metlife.com. MetLife will hold its third quarter 2026 earnings conference call on Thursday, November 5, 2026, from 9-10 a.m. (ET) via a live webcast. Please click on the following link to register:.
Hurricanes, market crashes, and rate shocks tend to destroy dividend streaks, but a handful of insurance stocks are engineered to keep paying through all three. The catch is that each one carries a specific vulnerability most income investors overlook.
MetLife, Inc. (NYSE: MET - Get Free Report) announced a quarterly dividend on Tuesday, October 6th. Shareholders of record on Tuesday, November 3rd will be paid a dividend of $0.5925 per share by the financial services provider on Tuesday, December 8th. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a fourth quarter 2026 common stock dividend of $0.5925 per share. The dividend will be payable on December 8, 2026, to shareholders of record as of November 3, 2026. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset managemen.
Michael Burry (Trades, Portfolio) is positioning several U.S. stock holdings around the year-end tax-loss selling period, while using option trades and portfoli
Argent Capital Management LLC purchased a new stake in MetLife, Inc. (NYSE: MET) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 121,303 shares of the financial services provider's stock, valued at approximately $11,422,000. Several other hedge funds have also modified their
MET's Group Benefits earnings jump 25% in Q2 2026, fueled by stronger underwriting and demand, but some mortality gains may fade.
Life insurers generally benefit from higher rates, but there are some negatives to consider.
Record annuity demand creates opportunities for Prudential, Principal Financial and MetLife as retirement needs and pension solutions grow.
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd.
WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the close of Galaxy 38 CLO, Ltd. (Galaxy 38), a $450 million target par new issue collateralized loan obligation (CLO). PineBridge Investments, which is part of MIM, serves as collateral manager for the transaction. BofA Securities, Inc. acted as arranger. Galaxy 38 marks the 45th CLO issuance by the Leveraged Finance team, building on t.
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) plus LAZCLUZE (lazertinib) with prophylactic strategies shows low rates of treatment-related events a
MetLife (NYSE: MET - Get Free Report) and Global Indemnity Group (NASDAQ: GBLI - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Valuation and Earnings This table compares MetLife and
NewEdge Advisors LLC boosted its stake in shares of MetLife, Inc. (NYSE: MET) by 20.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 74,002 shares of the financial services provider's stock after purchasing an additional 12,378 shares during